Antibacterial and Antiinflammatory Kinetics of Curcumin as a Potential Antimucositis Agent in Cancer Patients

VEGF non-angiogenic functions in adult organ homeostasis: therapeutic implications

(2011) Jincai Luo et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Incidence and risk factors of oral mucositis in paediatric and adolescent patients undergoing chemotherapy

(2011) Karis Kin Fong Cheng et al.   ORAL ONCOLOGY

VEGF-A and FGF gene therapy accelerate healing of ischemic colonic anastomoses (experimental study)

(2011) Gokhan Adas et al.   International Journal of Surgery

Serum levels of NF-κB and pro-inflammatory cytokines following administration of mucotoxic drugs

(2010) Richard M Logan et al.   CANCER BIOLOGY & THERAPY

MCP-1: Chemoattractant with a role beyond immunity: A review

(2010) Amita Yadav et al.   CLINICA CHIMICA ACTA

Topical curcumin can inhibit deleterious effects of upper respiratory tract bacteria on human oropharyngeal cells in vitro: potential role for patients with cancer therapy induced mucositis?

(2010) Sonja Lüer et al.   SUPPORTIVE CARE IN CANCER

The Role of Intestinal Microbiota in the Development and Severity of Chemotherapy-Induced Mucositis

(2010) Michel J. van Vliet et al.   PLoS Pathogens

Mucositis: The impact, biology and therapeutic opportunities of oral mucositis

(2009) Stephen T. Sonis   ORAL ONCOLOGY

Design, synthesis and characterization of some bioactive conjugates of curcumin with glycine, glutamic acid, valine and demethylenated piperic acid and study of their antimicrobial and antiproliferative properties

(2008) Shiv K. Dubey et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY